NDC 0409-6141
Physiosol
Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, And Magnesium Chloride
Physiosol is a Irrigation Irrigant in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Sodium Chloride; Sodium Acetate Anhydrous; Sodium Gluconate; Potassium Chloride; Magnesium Chloride.
| Product ID | 0409-6141_f9023ddc-a430-47a3-a7a9-ede847e8b974 |
| NDC | 0409-6141 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Physiosol |
| Generic Name | Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, And Magnesium Chloride |
| Dosage Form | Irrigant |
| Route of Administration | IRRIGATION |
| Marketing Start Date | 2011-02-11 |
| Marketing End Date | 2021-08-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017637 |
| Labeler Name | Hospira, Inc. |
| Substance Name | SODIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM GLUCONATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE |
| Active Ingredient Strength | 526 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
| NDC Exclude Flag | N |
Packaging
NDC 0409-6141-03
24 BOTTLE, PLASTIC in 1 CASE (0409-6141-03) > 500 mL in 1 BOTTLE, PLASTIC
| Marketing Start Date | 2011-02-11 |
| Marketing End Date | 2021-08-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0409-6141-09 [00409614109]
Physiosol IRRIGANT
| Marketing Category | NDA |
| Application Number | NDA017637 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-02-11 |
| Marketing End Date | 2021-08-01 |
NDC 0409-6141-03 [00409614103]
Physiosol IRRIGANT
| Marketing Category | NDA |
| Application Number | NDA017637 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-02-11 |
| Marketing End Date | 2021-08-01 |
NDC 0409-6141-22 [00409614122]
Physiosol IRRIGANT
| Marketing Category | NDA |
| Application Number | NDA017637 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-02-11 |
| Marketing End Date | 2021-08-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SODIUM CHLORIDE | 526 mg/100mL |
OpenFDA Data
| SPL SET ID: | fbae92f4-03ec-4c17-7faf-05c5f7a71af9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Potassium Compounds [CS]
- Potassium Salt [EPC]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Calculi Dissolution Agent [EPC]
- Magnesium Ion Exchange Activity [MoA]
- Osmotic Laxative [EPC]
- Osmotic Activity [MoA]
- Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
- Increased Large Intestinal Motility [PE]
- Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Potassium Compounds [CS]
- Potassium Salt [EPC]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Calculi Dissolution Agent [EPC]
- Magnesium Ion Exchange Activity [MoA]
- Osmotic Laxative [EPC]
- Osmotic Activity [MoA]
- Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
- Increased Large Intestinal Motility [PE]
- Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
NDC Crossover Matching brand name "Physiosol" or generic name "Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, And Magnesium Chloride"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-6141 | Physiosol | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE |
| 0990-6141 | Physiosol | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE |
| 0409-7670 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| 0409-7967 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| 0990-7670 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| 0990-7967 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
Trademark Results [Physiosol]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PHYSIOSOL 77429321 3495920 Live/Registered |
ICU MEDICAL, INC. 2008-03-24 |
 PHYSIOSOL 72449109 0978442 Dead/Expired |
ABBOTT LABORATORIES 1973-02-16 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.